| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Third Rock Ventures LP serves as a 10% Owner at CTMX and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 0 buys and 2 sells. Those positions are worth an estimated $358.2M at current prices.
The biggest single holding is RYTM (~$344.7M) as 10% Owner.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2017 | CTMX Cytomx Therapeutics, Inc. | 10% Owner | Sell | 1,650,000 | $17.39 | $28,700,395.00 | -13.1% |